Small-molecules

What are small molecules?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Business Strategy

Targeting Global Pharmaceutical Market with Step-by-step Growth Strategy

Starting with Temixys, the first HIV IMD to be approved by the US FDA, Celltrion takes the lead in the global generic pharmaceuticalmarket by entering the US and global tender markets and building its global distribution network.

Secure Presence in the Global Market

Develop IMDs and generic drugs
Enter the US and global tender markets
Perform initial clinical trials for new drugs

Acquire New Portfolios and Boost Global Sales

Develop IMDs and generic drugs
Enter the US and global tender markets
Perform initial clinical trials for new drugs

Become a Global Pharmaceutical Company

Develop IMDs and generic drugs
Enter the US and global tender markets
Perform initial clinical trials for new drugs

Production and quality control capabilities recognized by leading regulators

Equipped with chemical drug specialized R&D facility

World-class development, clinical trials and regulatory approval know-hows

Capable of manufacturing 5 billion tablets per year

Operates a stable SCM encompassing production and distribution

Continuous development of new, synthetic and generic drug pipeline

Business Capabilities

R&D